BEUDAMED
    12 results · 20ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    RAPIDONE-COCAINE-150 TEST

    FDA 510(k)
    FDA Class 2 ·Clinical Toxicology

    KMEDIC

    FDA UDI
    TELEFLEX INCORPORATED·24026704285345·

    JOBST forMen

    FDA UDI
    BSN MEDICAL, INC.·04042809842241·FOR MEN 30-40 MM HG KNEE HIGH OPEN TOE LARGE NA...

    Prime Medical LLC

    FDA UDI
    Prime Medical LLC·00850055249295·PrimePadPlus-K15-3422

    EDTA ROOT CANAL CLEANSER

    FDA 510(k)
    FDA Unclassified ·Unknown

    CARDIQ FUNCTION

    FDA 510(k)
    FDA Class 2 ·Radiology

    SIEMENS : ARTISTE MV

    FDA Adverse Event
    Malfunction ·SIEMENS MEDICAL SOLUTIONS USA, INC.·Product code IYE·July 30, 2010

    COMPLETE SE ILIAC

    FDA Adverse Event
    Malfunction ·MEDTRONIC IRELAND·Product code NIO·April 11, 2013

    SENSIA SR

    FDA Adverse Event
    Injury ·MEDTRONIC S.A.·Product code NVZ·April 13, 2011

    TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

    FDA Adverse Event
    Death ·BOSTON SCIENTIFIC CORPORATION·Product code NIQ·May 28, 2008

    Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

    FDA Enforcement
    Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

    Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

    FDA Enforcement
    Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014